Steris Stock 8-Day Winning Spree: Stock Climbs 14%
Steris (STE) stock hit day 8 of a continuous streak of days with gains, with cumulative gains over this period amounting to a 14% return. The company has gained about $3.2 Bil in value over the last 8 days, with its current market capitalization at about $26 Bil. The stock remains 31.4% above its value at the end of 2024. This compares with year-to-date returns of 16.5% for the S&P 500.
STERIS’s recent streak saw shares climb after crushing Q2 fiscal 2026 earnings. The medical tech firm reported adjusted EPS of $2.47 and lifted its full-year outlook to $10.15-$10.30, signaling robust demand for its infection prevention solutions.
What is the point? Momentum often precedes conviction. A multi-day win streak can signal growing investor confidence or spark follow-on buying. Tracking such trends can help you ride the strength, or prepare for a well-timed entry if momentum fades. Our take: There is a near-equal mix of good and bad in STE stock given its overall Moderate operating performance and financial condition. But keeping in mind its High valuation, we think that the stock is Unattractive (see Buy or Sell STE). Nevertheless, individual stocks can be volatile, but markets aren’t spared either – 2008, 2020. Volatility happens. See how Trefis’ Boston-based, wealth management partner’s asset allocation framework handled both.
For quick background, STE provides infection prevention products and services globally, specializing in healthcare cleaning, sterilization equipment, and life sciences consumables like cleaning chemicals and washer disinfectors.
Comparing STE Stock Returns With The S&P 500
The following table summarizes the return for STE stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | STE | S&P 500 |
|---|---|---|
| 1D | 0.5% | 0.1% |
| 8D (Current Streak) | 13.7% | 0.2% |
| 1M (21D) | 12.7% | 3.1% |
| 3M (63D) | 9.2% | 5.9% |
| YTD 2025 | 31.4% | 16.5% |
| 2024 | -5.6% | 23.3% |
| 2023 | 20.2% | 24.2% |
| 2022 | -23.4% | -19.4% |
Gains and Losses Streaks: S&P 500 Constituents
There are currently 113 S&P constituents with 3 days or more of consecutive gains and 13.0 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 30 | 13 |
| 4D | 47 | 0 |
| 5D | 17 | 0 |
| 6D | 11 | 0 |
| 7D or more | 8 | 0 |
| Total >=3 D | 113 | 13 |
Key Financials for Steris (STE)
Last 2 Fiscal Years:
| Metric | FY2024 | FY2025 |
|---|---|---|
| Revenues | $5.1 Bil | $5.5 Bil |
| Operating Income | $862.2 Mil | $960.8 Mil |
| Net Income | $378.2 Mil | $614.6 Mil |
Last 2 Fiscal Quarters:
| Metric | 2026 FQ1 | 2026 FQ2 |
|---|---|---|
| Revenues | $1.4 Bil | $1.5 Bil |
| Operating Income | $247.8 Mil | $268.0 Mil |
| Net Income | $177.4 Mil | $191.9 Mil |
While STE stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.